<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK548713" /><meta name="ncbi_domain" content="livertox" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK548713/" /><meta name="ncbi_pagename" content="Serotonin Receptor Agonists (Triptans) - LiverTox - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Serotonin Receptor Agonists (Triptans) - LiverTox - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.15.2/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.15.2/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]" /><meta name="citation_title" content="Serotonin Receptor Agonists (Triptans)" /><meta name="citation_publisher" content="National Institute of Diabetes and Digestive and Kidney Diseases" /><meta name="citation_date" content="2018/02/10" /><meta name="citation_pmid" content="31644023" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK548713/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Serotonin Receptor Agonists (Triptans)" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="National Institute of Diabetes and Digestive and Kidney Diseases" /><meta name="DC.Date" content="2018/02/10" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK548713/" /><meta name="description" content="The triptans are a group of serotonin receptor agonists that are useful in the therapy of vascular headaches and migraine. The triptans are generally used in low doses for a limited period of time and have not been associated with serum enzyme elevations, but some have been implicated in rare instances of clinically apparent, acute cholestatic hepatitis." /><meta name="og:title" content="Serotonin Receptor Agonists (Triptans)" /><meta name="og:type" content="book" /><meta name="og:description" content="The triptans are a group of serotonin receptor agonists that are useful in the therapy of vascular headaches and migraine. The triptans are generally used in low doses for a limited period of time and have not been associated with serum enzyme elevations, but some have been implicated in rare instances of clinically apparent, acute cholestatic hepatitis." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK548713/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-livertox-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/livertox/SerotoninRcptAgonist/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK548713/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D215904664681000000000A4402F6.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="protfam">Protein Family Models</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All Drug Records" href="/books/n/livertox/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-livertox-lrg.png" alt="Cover of LiverTox" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK548713_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK548713_dtls__"><div>Bethesda (MD): <a href="https://www.niddk.nih.gov/" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">National Institute of Diabetes and Digestive and Kidney Diseases</a>; 2012-.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/livertox/">Drug Records</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/livertox/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search this book" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search this book" submit="false" style="padding: 0.1em 0.4em;" /></div></form></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/livertox/S5HT4RcptAgonist/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/livertox/Sertraline/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK548713_"><span class="title" itemprop="name">Serotonin Receptor Agonists (Triptans)</span></h1><p class="small">Last Update: <span itemprop="dateModified">February 10, 2018</span>.</p></div><div class="body-content whole_rhythm" itemprop="text"><div id="SerotoninRcptAgonist.OVERVIEW"><h2 id="_SerotoninRcptAgonist_OVERVIEW_">OVERVIEW</h2><div id="SerotoninRcptAgonist.Introduction"><h3>Introduction</h3><p>The triptans are a group of serotonin receptor agonists that are useful in the therapy of vascular headaches and migraine. The triptans are generally used in low doses for a limited period of time and have not been associated with serum enzyme elevations, but some have been implicated in rare instances of clinically apparent, acute cholestatic hepatitis.</p></div><div id="SerotoninRcptAgonist.Background"><h3>Background</h3><p>The triptans (trip' tans) are synthetic serotonin receptor agonists that are used in the therapy of migraine and vascular headache. Serotonin (5-hydroxytryptamine or 5-HT) is a monoamine that has multiple actions, acting as a neurotransmitter and bioactive amine. The diversity of actions of serotonin is partially due to the multitude of different serotonin receptors and their tissue location. There are at least 15 classes of serotonin receptors which have overlapping actions, but variable distribution and intracellular pathways of response to stimulation and inhibition. The triptans are serotonin agonists with high affinity for the 5-HT1B and 5-HT1D receptors which are found on smooth-muscle cells of blood vessels. Simulation of the 5-HT1D receptor results in constriction of intracranial blood vessels. The triptans may also block the release of vasoactive peptides from perivascular trigeminal neurons through their action at presynaptic 5-HT1D receptors on nerve terminals. Regardless, the triptans have been found to be effective in preventing or aborting migraine headaches with shortening of the period of pain and symptoms. The triptans are considered &#x0201c;first line&#x0201d; agents for patients whose vascular headaches do not reliably respond to conventional analgesics. They generally have a more rapid onset of action and fewer side effects than the ergot alkaloids. Seven triptans are approved for use in the United States including almotriptan (al" moe trip' tan), eletriptan (el" e), forvatriptan (froe" va), naratriptan (nar"' a), rizatriptan (rye" za, sumatriptan (soo" ma) and zolmitriptan (zole" ma). Generic formulations are available for most agents. The short acting triptans include sumatriptan, almotriptan, eletriptan, rizatriptan and rolmitriptan and generally provide relief within 30 to 60 minutes. The longer activing oral triptans include naratriptan and frovatriptan which have a slower onset of action but may be better tolerated. Intranasal formulations may have a more rapid onset of action as do subcutaneous administered forms. Brand names, year approved, tablet or wafer size, usual dose and maximum daily recommended doses are shown in the Table.</p><div id="SerotoninRcptAgonist.T1" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK548713/table/SerotoninRcptAgonist.T1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__SerotoninRcptAgonist.T1_lrgtbl__"><table><thead><tr><th id="hd_h_SerotoninRcptAgonist.T1_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Generic (Brand) Name</th><th id="hd_h_SerotoninRcptAgonist.T1_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Year Approved</th><th id="hd_h_SerotoninRcptAgonist.T1_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Tablet (or Wafer) Size</th><th id="hd_h_SerotoninRcptAgonist.T1_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Usual Initial Dose</th><th id="hd_h_SerotoninRcptAgonist.T1_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">Maximum 24 Hour Dose</th></tr></thead><tbody><tr><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Almotriptan (Axert)</td><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">2001</td><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">6.25 and 12.5 mg</td><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">12.5 mg</td><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">25 mg</td></tr><tr><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Eletriptan (Relpax)</td><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">2002</td><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">20 and 40 mg</td><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">40 mg</td><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">80 mg</td></tr><tr><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Frovatriptan (Frova)</td><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">2001</td><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">2.5 mg</td><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">2.5 mg</td><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">7.5 mg</td></tr><tr><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Naratriptan (Amerge)</td><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">1998</td><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">1 and 2.5 mg</td><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">2.5 mg</td><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">5 mg</td></tr><tr><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Rizatriptan (Maxalt)</td><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">1998</td><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">5 and 10 mg</td><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">10 mg</td><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">30 mg</td></tr><tr><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Sumatriptan (Imitrex)</td><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">1997</td><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">25, 50 and 100 mg*</td><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">50 mg</td><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">200 mg</td></tr><tr><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Zolmitriptan (Zomig)</td><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">1997</td><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">2.5 mg and 5 mg**</td><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">5 mg</td><td headers="hd_h_SerotoninRcptAgonist.T1_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">10 mg</td></tr></tbody></table></div></div><p>* Also available as nasal spray, transdermal patch and solution for injection.</p><p>** Also available in orally disintegrating tablets and as nasal spray.</p><p>Early therapy is recommended in patients with recurrent migraine, and typically the dose is repeated in 2 to 4 hours if relief has not occurred. However, the total dosage should be limited to 2 to 3 doses per 24 hour period. Parenteral and intranasal administration is helpful in patients with nausea and vomiting. Chronic, long term use of triptans to prevent migraines has been studied, but is not currently approved. The seven triptans have similar side effect profiles which include &#x0201c;triptan sensations&#x0201d; characterized by tightening of the throat, chest, neck and limbs with paresthesias and hot or cold sensations. Triptans may also cause flushing, headache, somnolence and fatigue. Rare but potentially severe adverse events include medication overuse syndrome, cerebrovascular and cardiovascular events such as myocardial infarction and stroke, serotonin syndrome and anaphylaxis.</p></div><div id="SerotoninRcptAgonist.Hepatotoxicity"><h3>Hepatotoxicity</h3><p>In large prospective controlled trials, the different triptans have not been associated with serum enzyme elevations or hepatotoxicity; however, the frequency of monitoring in most studies was limited and rates of <a class="def" href="/books/n/livertox/glossary/def-item/glossary.alanine-aminotransferase-alt-/">ALT</a> elevations not reported. There have been rare individual reports of cholestatic hepatitis after the use of triptans, largely associated with zolmitriptan. Typically, the onset of injury was within 1 to 2 weeks of taking several doses of the zolmitriptan for a protracted and severe migraine attack. Recurrent jaundice with intermittent therapy has also been reported (Case 1). The pattern of serum enzyme elevations was mixed or cholestatic, and recovery was complete within 1 to 2 months. Allergic manifestations (rash, fever, eosinophilia) were not present and autoantibodies did not develop.</p><p>Likelihood score, zolmitriptan: D (probable rare cause of clinically apparent liver injury).</p><p>Likelihood score, rizatriptan: E* (suspected but unproven cause of liver injury).</p><p>Likelihood score, other triptans: E (unlikely cause of clinically apparent liver injury).</p></div><div id="SerotoninRcptAgonist.Mechanism_of_Injury"><h3>Mechanism of Injury</h3><p>The cause of idiosyncratic liver injury after triptan use is not known, but is likely due to a toxic metabolite causing an acute, cholestatic hepatitis-like injury. An intriguing hypothesis is that the serotonin agonist activity causes biliary dyskinesis and functional obstruction.</p></div><div id="SerotoninRcptAgonist.Outcome_and_Managem"><h3>Outcome and Management</h3><p>Reported cases of hepatotoxicity from the triptans have been mild-to-moderate in severity, accompanied by symptoms and jaundice, but without acute liver failure, chronic hepatitis or vanishing bile duct syndrome. There have been too few cases reported to know whether there is cross sensitivity to hepatotoxicity among the various triptans. <a class="def" href="/books/n/livertox/glossary/def-item/glossary.rechallenge/">Rechallenge</a> should be avoided and switching to another triptan should be done with caution.</p><p>Agents used specifically in management of migraines and vascular headaches include: the ergot alkaloids, ergotamine and dihydroergotamine; and, the serotonin receptor agonists (triptans), including almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, sumatriptan and zolmitriptan.</p><p>Drug Class: <a href="/books/n/livertox/MigraineHeadacheAgen/">Migraine Headache Agents</a>, Vasoconstrictor Agents</p></div></div><div id="SerotoninRcptAgonist.CASE_REPORT"><h2 id="_SerotoninRcptAgonist_CASE_REPORT_">CASE REPORT</h2><div id="SerotoninRcptAgonist.Case_1._Recurrent_j"><h3>Case 1. Recurrent jaundice in a patient taking zolmitriptan for migraine headaches.</h3><p>[Modified from: Deixler E, Helmke K. [Extrahepatic cholestasis during therapy with zolmitriptan (AscoTop)]. Z Gastroenterol 2005; 43: 1045-9. German. <a href="https://www.ncbi.nlm.nih.gov/pubmed/16142613" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PubMed Citation</a>]</p><p>A 62 year old man developed recurrent episodes of jaundice and abdominal pain approximately 6 months after starting zolmitriptan (5 mg, averaging 3-4 times weekly) for migraine headaches. During an early attack, serum bilirubin was 6.6 mg/dL (4.5 mg/dL direct), <a class="def" href="/books/n/livertox/glossary/def-item/glossary.alanine-aminotransferase-alt-/">ALT</a> 230 U/L, Alk P 350 U/L, <a class="def" href="/books/n/livertox/glossary/def-item/glossary.gamma-glutamyl-transpeptidase-ggt-/">GGT</a> 375 U/L (Table). Tests for hepatitis A, B and C were negative as were routine autoantibodies. Because of recurrent bouts of jaundice were suggestive of cholangitis, he underwent cholecystectomy. Histologically, the gallbladder showed evidence of chronic inflammation, but was without stones and the extrahepatic biliary tree appeared normal. Three months after cholecystectomy, jaundice recurred. Endoscopic retrograde cholangiopancreatography again failed to show evidence of extrahepatic obstruction, but suggested dysfunction of the ampula of Vater. At that point, total serum bilirubin was 7.8 mg/dL, ALT 680 U/L, and alkaline phosphatase 205 U/L. Because zolmitriptan is a serotonin agonist and might affect gastrointestinal and biliary smooth muscle function, it was discontinued, whereupon liver test abnormalities rapidly improved. During a year of follow up, he had no further attacks of jaundice or abdominal pain and liver tests were repeatedly normal. His migraine headaches were managed with beta-blockers.</p><div id="SerotoninRcptAgonist.Key_Points"><h4>Key Points</h4><div id="SerotoninRcptAgonist.T2" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK548713/table/SerotoninRcptAgonist.T2/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__SerotoninRcptAgonist.T2_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="vertical-align:top;">Medication:</td><td rowspan="1" colspan="1" style="vertical-align:top;">Zolmitriptan (5 mg 3-4 times weekly)</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;">Pattern:</td><td rowspan="1" colspan="1" style="vertical-align:top;">Mixed (R=2.7)</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;">Severity:</td><td rowspan="1" colspan="1" style="vertical-align:top;">3+ (jaundice, hospitalization)</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.latency/">Latency</a>:</td><td rowspan="1" colspan="1" style="vertical-align:top;">Six months</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;">Recovery:</td><td rowspan="1" colspan="1" style="vertical-align:top;">One month</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;">Other medications:</td><td rowspan="1" colspan="1" style="vertical-align:top;">None</td></tr></tbody></table></div></div></div><div id="SerotoninRcptAgonist.Laboratory_Values"><h4>Laboratory Values</h4><div id="SerotoninRcptAgonist.T3" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK548713/table/SerotoninRcptAgonist.T3/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__SerotoninRcptAgonist.T3_lrgtbl__"><table><thead><tr><th id="hd_h_SerotoninRcptAgonist.T3_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Time After Starting</th><th id="hd_h_SerotoninRcptAgonist.T3_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Time After Stopping</th><th id="hd_h_SerotoninRcptAgonist.T3_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.alanine-aminotransferase-alt-/">ALT</a>* (U/L)</th><th id="hd_h_SerotoninRcptAgonist.T3_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Alk P* (U/L)</th><th id="hd_h_SerotoninRcptAgonist.T3_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.bilirubin/">Bilirubin</a>* (mg/dL)</th><th id="hd_h_SerotoninRcptAgonist.T3_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Other</th></tr></thead><tbody><tr><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_3 hd_h_SerotoninRcptAgonist.T3_1_1_1_4 hd_h_SerotoninRcptAgonist.T3_1_1_1_5 hd_h_SerotoninRcptAgonist.T3_1_1_1_6" colspan="4" rowspan="1" style="vertical-align:top;">Zolmitriptan started for migraine headaches</td></tr><tr><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">6 months</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">0</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">40</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">210</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">1.6</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Abdominal pain</td></tr><tr><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">7 months</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">0</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">30</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">200</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">1.2</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">8 months</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">0</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">110</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">360</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">6.6</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.cholecystectomy/">Cholecystectomy</a></td></tr><tr><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">9 months</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">0</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">90</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">200</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">1.2</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">12 months</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">0</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">690</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">218</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">7.8</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ERCP</td></tr><tr><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_3 hd_h_SerotoninRcptAgonist.T3_1_1_1_4 hd_h_SerotoninRcptAgonist.T3_1_1_1_5 hd_h_SerotoninRcptAgonist.T3_1_1_1_6" colspan="4" rowspan="1" style="vertical-align:top;">Zolmitriptan stopped</td></tr><tr><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">13 months</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">1 month</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">50</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">105</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">1.1</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">14 months</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">2 months</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">25</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">90</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">1.0</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">18 months</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">6 months</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">25</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">70</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">1.0</td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_1 hd_h_SerotoninRcptAgonist.T3_1_1_1_2" colspan="2" rowspan="1" style="vertical-align:top;"><b>Normal Values</b></td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;35</b></td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;130</b></td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;1.2</b></td><td headers="hd_h_SerotoninRcptAgonist.T3_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr></tbody></table></div></div><p>* Selected values estimated from Figure 1.</p></div><div id="SerotoninRcptAgonist.Comment"><h4>Comment</h4><p>This patient had intermittent and fluctuating jaundice that suggested intermittent extrahepatic obstruction due to choledocholithiasis. The possibility that zolmitriptan was the cause arose only after repeated evaluations failed to show frank extrahepatic obstruction, but indicated biliary akinesia or abnormalities in the function of the ampula of Vater. The intermittency and variable doses of the migraine medication made it difficult to incriminate its use and perhaps explained the fluctuating course of liver injury. The possibility that the triptans may affect biliary kinesis is intriguing (but unproven) explanation for occasional instances of cholestatic jaundice.</p></div></div></div><div id="SerotoninRcptAgonist.PRODUCT_INFORMATION"><h2 id="_SerotoninRcptAgonist_PRODUCT_INFORMATION_">PRODUCT INFORMATION</h2><div id="SerotoninRcptAgonist.BPI" class="box"><p><b>REPRESENTATIVE TRADE NAMES</b></p><p>Almotriptan &#x02013; Generic, Almogran&#x000ae;, Axert&#x000ae;</p><p>Eletriptan &#x02013; Relpax&#x000ae;</p><p>Frovatriptan &#x02013; Frova&#x000ae;</p><p>Naratriptan &#x02013; Generic, Amerge&#x000ae;</p><p>Rizatriptan &#x02013; Maxalt&#x000ae;</p><p>Sumatriptan &#x02013; Generic, Imitrex&#x000ae;</p><p>Zolmitriptan &#x02013; Zomig&#x000ae;</p><p><b>DRUG CLASS</b></p><p>Migraine Headache Agents</p><p><a href="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&#x00026;query=triptans" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COMPLETE LABELING</a></p><p>Product labeling at DailyMed, National Library of Medicine, NIH</p></div></div><div id="SerotoninRcptAgonist.CHEMICAL_FORMULAS_A"><h2 id="_SerotoninRcptAgonist_CHEMICAL_FORMULAS_A_">CHEMICAL FORMULAS AND STRUCTURES</h2><div id="SerotoninRcptAgonist.T4" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK548713/table/SerotoninRcptAgonist.T4/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__SerotoninRcptAgonist.T4_lrgtbl__"><table><thead><tr><th id="hd_h_SerotoninRcptAgonist.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">DRUG</th><th id="hd_h_SerotoninRcptAgonist.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">CAS REGISTRY NUMBER</th><th id="hd_h_SerotoninRcptAgonist.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">MOLECULAR FORMULA</th><th id="hd_h_SerotoninRcptAgonist.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">STRUCTURE</th></tr></thead><tbody><tr><td headers="hd_h_SerotoninRcptAgonist.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Almotriptan</td><td headers="hd_h_SerotoninRcptAgonist.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/135078946" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">154323-57-6</a></td><td headers="hd_h_SerotoninRcptAgonist.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">C17-H25-N3-O2-S</td><td headers="hd_h_SerotoninRcptAgonist.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><div class="graphic"><img src="/books/NBK548713/bin/Almotriptan_Structure.jpg" alt="Almotriptan Chemical Structure" /></div></td></tr><tr><td headers="hd_h_SerotoninRcptAgonist.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Eletriptan</td><td headers="hd_h_SerotoninRcptAgonist.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/135112667" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">177834-92-3</a></td><td headers="hd_h_SerotoninRcptAgonist.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">C22-H26-N2-O2-S.Br-H</td><td headers="hd_h_SerotoninRcptAgonist.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><div class="graphic"><img src="/books/NBK548713/bin/Eletriptan_Structure.jpg" alt="Eletriptan Chemical Structure" /></div></td></tr><tr><td headers="hd_h_SerotoninRcptAgonist.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Frovatriptan</td><td headers="hd_h_SerotoninRcptAgonist.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/135109199" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">158930-17-7</a></td><td headers="hd_h_SerotoninRcptAgonist.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">C14-H17-N3-O.C4-H6-O4.H2-O</td><td headers="hd_h_SerotoninRcptAgonist.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><div class="graphic"><img src="/books/NBK548713/bin/Frovatriptan_Structure.jpg" alt="Frovatriptan Chemical Structure" /></div></td></tr><tr><td headers="hd_h_SerotoninRcptAgonist.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Naratriptan</td><td headers="hd_h_SerotoninRcptAgonist.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/135035417" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">121679-13-8</a></td><td headers="hd_h_SerotoninRcptAgonist.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">C17-H25-N3-O2-S</td><td headers="hd_h_SerotoninRcptAgonist.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><div class="graphic"><img src="/books/NBK548713/bin/Naratriptan_Structure.jpg" alt="Naratriptan Chemical Structure" /></div></td></tr><tr><td headers="hd_h_SerotoninRcptAgonist.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Rizatriptan</td><td headers="hd_h_SerotoninRcptAgonist.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/135110600" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">144034-80-0</a></td><td headers="hd_h_SerotoninRcptAgonist.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">C15-H19-N5</td><td headers="hd_h_SerotoninRcptAgonist.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><div class="graphic"><img src="/books/NBK548713/bin/Rizatriptan_Structure.jpg" alt="Rizatriptan Chemical Structure" /></div></td></tr><tr><td headers="hd_h_SerotoninRcptAgonist.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Sumatriptan</td><td headers="hd_h_SerotoninRcptAgonist.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/135018088" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">103628-46-2</a></td><td headers="hd_h_SerotoninRcptAgonist.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">C14-H21-N3-O2-S</td><td headers="hd_h_SerotoninRcptAgonist.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><div class="graphic"><img src="/books/NBK548713/bin/Sumatriptan_Structure.jpg" alt="Sumatriptan Chemical Structure" /></div></td></tr><tr><td headers="hd_h_SerotoninRcptAgonist.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Zolmitriptan</td><td headers="hd_h_SerotoninRcptAgonist.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/135017989" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">139264-17-8</a></td><td headers="hd_h_SerotoninRcptAgonist.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">C16-H21-N3-O2</td><td headers="hd_h_SerotoninRcptAgonist.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><div class="graphic"><img src="/books/NBK548713/bin/Zolmitriptan_Structure.jpg" alt="Zolmitriptan Chemical Structure" /></div></td></tr></tbody></table></div></div></div><div id="SerotoninRcptAgonist.REFERENCES_Migraine"><h2 id="_SerotoninRcptAgonist_REFERENCES_Migraine_">REFERENCES</h2><p>References updated: 10 February 2018</p><ul class="first-line-outdent"><li><div class="bk_ref" id="SerotoninRcptAgonist.R1">Zimmerman HJ. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. 2nd ed. Philadelphia: Lippincott, 1999.<div><i>(Expert review of hepatotoxicity published in 1999; ergotamine and triptans are not discussed).</i></div></div></li><li><div class="bk_ref" id="SerotoninRcptAgonist.R2">Larrey D, Ripault MP. Benzodiazepines. Hepatotoxicity of psychotropic drugs and drugs of abuse. In, Kaplowitz N, DeLeve LD, eds. Drug-induced liver disease. 3rd ed. Amsterdam: Elsevier, 2013, pp. 455. <em>(Review of hepatotoxicity of neuroleptic drugs does not mention</em>.<div><i>ergotamine or the triptans).</i></div></div></li><li><div class="bk_ref" id="SerotoninRcptAgonist.R3">Sanders-Bush E, Mayer SE. 5-Hydroxytryptamine (Serotonin): receptor agonists and antagonists. In, Brunton LL, Lazo JS, Parker KL, eds. Goodman &#x00026; Gilman's the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill, 2006, pp. 297-315.<div><i>(Textbook of pharmacology and therapeutics).</i></div></div></li><li><div class="bk_ref" id="SerotoninRcptAgonist.R4">Block GA, Goldstein J, Polis A, Reines SA, Smith ME. Efficacy and safety of rizatriptan versus standard care during long-term treatment for migraine. Rizatriptan Multicenter Study Groups. Headache 1998; 38: 764-71.  [<a href="/pubmed/11284464" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11284464</span></a>]<div><i>(Among 1831 patients treated for up to 12 months and experiencing 46,773 migraine attacks, pain relief was achieved in 2 hours in 80-90% on rizatriptan and 70% on standard care; side effects were similar and there were &#x0201c;no meaningful differences in the incidences of drug related laboratory adverse events&#x0201d;).</i></div></div></li><li><div class="bk_ref" id="SerotoninRcptAgonist.R5">O'Quinn S, Davis RL, Gutterman DL, Pait GD, Fox AW. Prospective large-scale study of the tolerability of subcutaneous sumatriptan injection for acute treatment of migraine. Cephalalgia 1999; 19: 223-31.  [<a href="/pubmed/10376167" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10376167</span></a>]<div><i>(Among 12,339 patients in an open-label study of sumatriptan injections for migraine attacks, 4.1% had a serious adverse event, but only 20 [0.2%] were considered related to sumatriptan and none were hepatic).</i></div></div></li><li><div class="bk_ref" id="SerotoninRcptAgonist.R6">Heywood J, Bomhof MA, Pradalier A, Thaventhiran L, Winter P, Hassani H. Tolerability and efficacy of naratriptan tablets in the acute treatment of migraine attacks for 1 year. Naratriptan Long-Term Study Group. Cephalalgia 2000; 20: 470-4.  [<a href="/pubmed/11037743" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11037743</span></a>]<div><i>(Among 417 patients with 15,301 migraine attacks in an open-label study of naratriptan, the most common side effects were nausea, salivation and drowsiness [2-3%] and no mention of hepatitis or liver related adverse events).</i></div></div></li><li><div class="bk_ref" id="SerotoninRcptAgonist.R7">Geraud G, Compagnon A, Rossi A; COZAM Study Group. Zolmitriptan versus a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: a double-blind, randomised, three-attack study. Eur Neurol 2002; 47: 88-98.  [<a href="/pubmed/11844897" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11844897</span></a>]<div><i>(Among 666 patients with migraine treated with either zolmitriptan or aspirin/metoclopramide, side effects of paresthesias and dizziness were more common with zolmitriptan; no mention of any hepatic side effects).</i></div></div></li><li><div class="bk_ref" id="SerotoninRcptAgonist.R8">Diener HC, Jansen JP, Reches A, Pascual J, Pitei D, Steiner TJ; Eletriptan and Cafergot Comparative Study Group. Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison. Eur Neurol 2002; 47: 99-107.  [<a href="/pubmed/11844898" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11844898</span></a>]<div><i>(Among 733 patients with migraine treated with either eletriptan or ergotamine/caffeine, side effects were transient and predominately mild or moderate; &#x0201c;No clinically significant laboratory&#x02026;abnormalities were recorded&#x0201d;).</i></div></div></li><li><div class="bk_ref" id="SerotoninRcptAgonist.R9">Snow V, Weiss K, Wall EM, Mottur-Pilson C; American Academy of Family Physicians; American College of Physicians-American Society of Internal Medicine. Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Ann Intern Med 2002; 137: 840-9.  [<a href="/pubmed/12435222" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12435222</span></a>]<div><i>(Guidelines for management of acute migraine and chronic prevention; recommends use of nasal dihydroergotamine or a triptan in patients whose migraines fail to respond to aspirin, acetaminophen or nonsteroidal antiinflammatory agents).</i></div></div></li><li><div class="bk_ref" id="SerotoninRcptAgonist.R10">Jamieson DG. The safety of triptans in the treatment of patients with migraine. Am J Med 2002; 112: 135-40.  [<a href="/pubmed/11835952" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11835952</span></a>]<div><i>(Review of the safety of triptans in migraine therapy focusing on vascular risk, stroke, myocardial infarction and ischemic bowel disease; no mention of hepatotoxicity).</i></div></div></li><li><div class="bk_ref" id="SerotoninRcptAgonist.R11">Redondo Cerezo E, Espinosa Aguilar MD, Nogueras L&#x000f3;pez F, Mart&#x000ed;n-Vivaldi Mart&#x000ed;nez R. [Zolmitriptan-induced hepatotoxicity]. Gastroenterol Hepatol 2003; 26: 664. Spanish.  [<a href="/pubmed/14670242" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14670242</span></a>]<div><i>(48 year old woman developed jaundice and itching one week after taking three doses of zolmitriptan for a severe bout of migraine [bilirubin 4.3 mg/dL, ALT 331 U/L, Alk P 530 U/L], resolving spontaneously and no rechallenge).</i></div></div></li><li><div class="bk_ref" id="SerotoninRcptAgonist.R12">Ashcroft DM, Millson D. Naratriptan for the treatment of acute migraine: meta-analysis of randomised controlled trials. Pharmacoepidemiol Drug Saf 2004; 13: 73-82.  [<a href="/pubmed/14998068" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14998068</span></a>]<div><i> (Metaanalysis of 10 trials of naratriptan for acute migraine with 4499 participants found lower rates of adverse effects with naratriptan compared to other triptans, but specifics of side effects were not provided; no mention of ALT elevations or liver injury).</i></div></div></li><li><div class="bk_ref" id="SerotoninRcptAgonist.R13">Deixler E, Helmke K. [Extrahepatic cholestasia during therapy with Zolmitriptan (AscoTop)]. Z Gastroenterol 2005; 43: 1045-9. German.  [<a href="/pubmed/16142613" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16142613</span></a>]<div><i>(62 year old man developed recurrent, fluctuating jaundice and abdominal pain 6 months after starting zolmitriptan [3-4 times weekly] for migraine [bilirubin 7.8 mg/dL, ALT 690 U/L, Alk P 218 U/L], which recurred after cholecystectomy, but resolved within a month of stopping zolmitriptan: Case 1).</i></div></div></li><li><div class="bk_ref" id="SerotoninRcptAgonist.R14">Loj J, Solomon GD. Migraine prophylaxis: who, why, and how. Cleve Clin J Med 2006; 73: 793-4, 797, 800-1 passim.  [<a href="/pubmed/16970133" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16970133</span></a>]<div><i>(Preventive therapy of migraine has limited efficacy and may take 2-3 months to have an effect; the most commonly used agents are beta-blockers, calcium channel blockers, anticonvulsants, tricyclic antidepressants and selective serotonin reuptake inhibitors [SSRIs]).</i></div></div></li><li><div class="bk_ref" id="SerotoninRcptAgonist.R15">Chen LC, Ashcroft DM. Meta-analysis examining the efficacy and safety of almotriptan in the acute treatment of migraine. Headache 2007; 47: 1169-77.  [<a href="/pubmed/17883521" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17883521</span></a>]<div><i>(Metaanalysis of 8 controled trials of almotriptan for acute migraine with 4995 participants; no mention of ALT elevations or hepatotoxicity).</i></div></div></li><li><div class="bk_ref" id="SerotoninRcptAgonist.R16">Chen LC, Ashcroft DM. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine. Headache 2008; 48: 236-47.  [<a href="/pubmed/18179569" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18179569</span></a>]<div><i>(Metaanalysis of 24 controled trials of zolmitriptan for acute migraine with 15,408 participants; no mention of ALT elevations or hepatotoxicity).</i></div></div></li><li><div class="bk_ref" id="SerotoninRcptAgonist.R17">Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, Yang H, Rochon J; Drug Induced Liver Injury Network (DILIN). Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008; 135: 1924-34.  [<a href="/pmc/articles/PMC3654244/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3654244</span></a>] [<a href="/pubmed/18955056" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18955056</span></a>]<div><i>(Among 300 cases of drug induced liver disease in the US collected from 2004 to 2008, none were attributed to agents used to treat migraine headaches).</i></div></div></li><li><div class="bk_ref" id="SerotoninRcptAgonist.R18">Whyte CA, Tepper SJ. Adverse effects of medications commonly used in the treatment of migraine. Expert Rev Neurother 2009; 9: 1379-91.  [<a href="/pubmed/19769452" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19769452</span></a>]<div><i>(Extensive review of common side effects of medications used to treat migraine; 1-8% of patients who take triptans develop &#x0201c;triptan sensations with throat and chest tightness, numbness and tingling and hot/cold sensations which may vary with different forms&#x0201d;).</i></div></div></li><li><div class="bk_ref" id="SerotoninRcptAgonist.R19">Loder E. Triptan therapy in migraine. N Engl J Med 2010; 363: 63-70.  [<a href="/pubmed/20592298" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20592298</span></a>]<div><i>(Review of the pathophysiology of migraine headache and the mechanism of action, efficacy, tolerance and safety of the serotonin receptor agonists [triptans]; no mention of ALT elevations of clinically apparent liver injury).</i></div></div></li><li><div class="bk_ref" id="SerotoninRcptAgonist.R20">Taylor FR. Acute treatment of migraine headaches. Semin Neurol 2010; 30: 145-53.  [<a href="/pubmed/20352584" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20352584</span></a>]<div><i>(Review of diagnosis and acute management of migraine headaches).</i></div></div></li><li><div class="bk_ref" id="SerotoninRcptAgonist.R21">Berenson F, Vasconcellos E, Pakalnis A, Mao L, Biondi DM, Armstrong RB. Long-term, open-label safety study of oral almotriptan 12.5 mg for the acute treatment of migraine in adolescents. Headache 2010; 50: 795-807.  [<a href="/pubmed/20546320" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20546320</span></a>]<div><i>(Among 319 adolescents with migraine headache treated with almotriptan for 12 months, "minor changes (increases and decreases) in mean values for hematology, serum, chemistry and urinalysis parameters were observed, but there were no consistent trends").</i></div></div></li><li><div class="bk_ref" id="SerotoninRcptAgonist.R22">Drugs for migraine. Treat Guidel Med Lett 2011; 9: 7-12.  [<a href="/pubmed/21304447" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21304447</span></a>]<div><i>(Concise review of current medications used for migraine; no discussion of hepatotoxicity).</i></div></div></li><li><div class="bk_ref" id="SerotoninRcptAgonist.R23">Fernandez-Atutxa A, Vergara M, Gil M, Dalmau B, Miquel M, Sanchez-Delgado J, Casas M. [Rizatriptan-induced liver toxicity. Report of a case]. Gastroenterol Hepatol 2013; 36: 261-3. Spanish.  [<a href="/pubmed/23084593" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23084593</span></a>]<div><i>(17 year old girl with migraines developed jaundice [bilirubin 7.1 mg/dL, ALT 9729 U/L, Alk P normal] two weeks after taking a 10 mg tablet of rizatriptan).</i></div></div></li><li><div class="bk_ref" id="SerotoninRcptAgonist.R24">Hern&#x000e1;ndez N, Bessone F, S&#x000e1;nchez A, di Pace M, Brahm J, Zapata R, A Chirino R, et al. Profile of idiosyncratic drug induced liver injury in Latin America: an analysis of published reports. Ann Hepatol 2014; 13: 231-9.  [<a href="/pubmed/24552865" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24552865</span></a>]<div><i>(Among 176 reports of drug induced liver injury from Latin America published between 1996 and 2012, none were attributed to drugs for migraine headaches).</i></div></div></li><li><div class="bk_ref" id="SerotoninRcptAgonist.R25">Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, Reddy KR, et al.; United States Drug Induced Liver Injury Network. Features and outcomes of 899 patients with drug-induced liver injury: The DILIN Prospective Study. Gastroenterology 2015; 148: 1340-52.e7.  [<a href="/pmc/articles/PMC4446235/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4446235</span></a>] [<a href="/pubmed/25754159" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25754159</span></a>]<div><i>(Among 899 cases of drug induced liver injury enrolled in a US prospective study between 2004 and 2013, none were attributed to the triptans or other drugs for migraine headaches). </i></div></div></li><li><div class="bk_ref" id="SerotoninRcptAgonist.R26">Drugs for migraine. Med Lett Drugs Ther 2017; 59 (1514): 27-32. <em>Corrected and republished in: JAMA 2017; 317 (21): 2230-1.  <a href="https://www.ncbi.nlm.nih.gov/pubmed/28586886" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PubMed Citation</a>
</em>. [<a href="/pubmed/28170366" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28170366</span></a>]<div><i>(Concise review of current medications used for migraine; no discussion of hepatotoxicity).</i></div></div></li></ul></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright Notice</a></div><div class="small"><span class="label">Bookshelf ID: NBK548713</span><span class="label">PMID: <a href="/pubmed/31644023" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">31644023</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/livertox/">Drug Records</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/livertox/S5HT4RcptAgonist/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/livertox/Sertraline/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK548713&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK548713/?report=reader">PubReader</a></li><li><a href="/books/NBK548713/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK548713" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK548713" style="display:none" title="Cite this Page"><div class="bk_tt">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.  Serotonin Receptor Agonists (Triptans) [Updated 2018 Feb 10].<span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK548713/pdf/Bookshelf_NBK548713.pdf">PDF version of this page</a> (153K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Bulk Download</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://ftp.ncbi.nlm.nih.gov/pub/litarch/29/31/" ref="pagearea=source-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Bulk download LiverTox data from FTP</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Overviews</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/livertox/intro/">Introduction</a></li><li><a href="/books/n/livertox/Causality/">Causality</a></li><li><a href="/books/n/livertox/ClinicalCourse/">Clinical Course</a></li><li><a href="/books/n/livertox/ClinicalOutcome/">Clinical Outcomes</a></li><li><a href="/books/n/livertox/ImmuneFeatures/">Immune Features</a></li><li><a href="/books/n/livertox/DrugCategory/">Likelihood Scale</a></li><li><a href="/books/n/livertox/Phenotypes_intro/">Phenotypes</a></li><li><a href="/books/n/livertox/Severity/">Severity Grading</a></li><li><a href="/books/n/livertox/CaseReport/">Writing a Case Report</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Support Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/livertox/">LiverTox Homepage</a></li><li><a href="/books/n/livertox/aboutus/">About LiverTox</a></li><li><a href="/books/n/livertox/editorsandreviewers/">Editors and Review Committee</a></li><li><a href="/books/n/livertox/alert/">Meetings and News</a></li><li><a href="/books/n/livertox/abbreviation/">Abbreviations Used</a></li><li><a href="/books/n/livertox/glossary/">Glossary</a></li><li><a href="/books/n/livertox/resource/">Information Resources</a></li><li><a href="/books/n/livertox/disclaimer/">User/Medical Advice Disclaimer</a></li><li><a href="/books/n/livertox/Contactus/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>OTHER REFERENCE LINKS</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;pubmedfilters=true&amp;term=(triptans/AE)+AND+Human%5BMH%5D+AND+(drug+induced+liver+injury+OR+jaundice/CI+OR+bile+duct+diseases/CI+OR+liver/DE+OR+liver+diseases/CI)+AND+(%221900/1/1%22%5BEDat%5D%3A%222999/12/31%22%5BEDat%5D)" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Recent References on Triptans: from PubMed.gov</a></li><li><a href="https://clinicaltrials.gov/ct2/results?term=triptans" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Trials on Triptans: from ClinicalTrials.gov</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4862260" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pcsubstance&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pcsubstance&amp;IdsFromResult=4862260" ref="log$=recordlinks">PubChem Substance</a><div class="brieflinkpop offscreen_noflow">Related PubChem Substances</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4862260" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22644202" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Triptans: over the migraine.</a><span class="source">[Neurol Sci. 2012]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Triptans: over the migraine.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Cologno D, Mazzeo A, Lecce B, Mundi C, Petretta V, Casucci G, d'Onofrio F. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Neurol Sci. 2012 May; 33 Suppl 1:S193-8. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/12383060" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.</a><span class="source">[Cephalalgia. 2002]</span><div class="brieflinkpop offscreen_noflow">Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ferrari MD, Goadsby PJ, Roon KI, Lipton RB. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Cephalalgia. 2002 Oct; 22(8):633-58. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/14613452" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Evaluation of a monthly coverage maximum (drug-specific quantity limit) on the 5-HT1 agonists (triptans) and dihydroergotamine nasal spray.</a><span class="source">[J Manag Care Pharm. 2003]</span><div class="brieflinkpop offscreen_noflow">Evaluation of a monthly coverage maximum (drug-specific quantity limit) on the 5-HT1 agonists (triptans) and dihydroergotamine nasal spray.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Hoffman L, Mayzell G, Pedan A, Farrell M, Gilbert T. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Manag Care Pharm. 2003 Jul-Aug; 9(4):335-45. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/11999139" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Usage of triptans among migraine patients: an audit in nine GP practices.</a><span class="source">[Curr Med Res Opin. 2002]</span><div class="brieflinkpop offscreen_noflow">Usage of triptans among migraine patients: an audit in nine GP practices.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Williams D, Cahill T, Dowson A, Fearon H, Lipscombe S, O'Sullivan E, Rees T, Strang C, Valori A, Watson D. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Curr Med Res Opin. 2002; 18(1):1-9. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21929465" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Pharmacokinetic evaluation of frovatriptan.</a><span class="source">[Expert Opin Drug Metab Toxicol...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Pharmacokinetic evaluation of frovatriptan.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Negro A, Lionetto L, Casolla B, Lala N, Simmaco M, Martelletti P. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Expert Opin Drug Metab Toxicol. 2011 Nov; 7(11):1449-58. Epub 2011 Sep 20.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=31644023" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=31644023" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class="&#10;                        HTOn&#10;                    "><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2021-03-08T16:11:44-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@9.2&amp;Host=portal106&amp;ncbi_phid=CE8D215904664681000000000A4402F6&amp;ncbi_session=CE8D2159046930E1_2628SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK548713%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK548713&amp;ncbi_domain=livertox&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK548713/&amp;ncbi_pagename=Serotonin Receptor Agonists (Triptans) - LiverTox - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8D2159046930E1_2628SID /projects/books/PBooks@9.2 portal106 v4.1.r621975 Fri, Dec 18 2020 02:56:50 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>